Enhanced methodology for analysis cytotoxicity of ruthenium dendrimers
Methods · 2025
DOI: 10.1016/j.ymeth.2025.02.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2025. Verfasst von Aneta Węgierek-Ciuk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jan Kochanowski University, Institute of Biology, Uniwersytecka 7, 25-406 Kielce, Poland. Electronic address: aneta.wegierek-ciuk@ujk.edu.pl. Hauptthemen laut MEDLINE: Dendrimers, Ruthenium, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Resistance of cancer cells to chemotherapy is one of the major causes of treatment failure and poor patient survival. Reduced cellular response to drugs can result from their genetic diversity, acquired mutations of drug targets, epigenetic modifications and many others. Metallodendrimers, in particular, ruthenium dendrimers of the first and second generation are promising novel anticancer drug carriers, as their usage can result in increased drug concentration in tumour tissue and reduced toxicity in healthy tissues. However the conventional, biological methods do not provide sufficient knowledge about cytotoxicity of these compounds. Therefore in the paper we propose an efficient, multimodal methodology for cytotoxicity studies at cellular level. It combines the conventional flow cytometry method (Annexin V-FITC assay), which provides global/statistical information about a cell culture, and digital holographic microscopy (DHM) allowing for continuous quantitative monitoring of cells behaviour and identifying cells with non-standard behaviour. The results reveal that tested ruthenium metallodendrimers have a strong impact on apoptotic and necrotic death of both human alveolar epithelial cell line A549 and Chinese hamster ovary cell line CHO-K1. We also have shown that DHM enables detection of the individual, drug resistance cells, through real-time monitoring of a single cell. We believe that the methodology proposed is a necessary supplement to conventional approach for studying drug cytotoxicity, which will help, in the near future, to overcome the problem of cellular resistance to anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jan Kochanowski University, Institute of Biology, Uniwersytecka 7, 25-406 Kielce, Poland. Electronic address: aneta.wegierek-ciuk@ujk.edu.pl.
- Warsaw University of Technology, Institute of Micromechanics and Photonics, St A. Boboli 8 St., 02-525 Warsaw, Poland.
- Jan Kochanowski University, Institute of Biology, Uniwersytecka 7, 25-406 Kielce, Poland; Central Office of Measures, Elektoralna 2, 00-139 Warsaw, Poland.
- University of Alcalá, Department of Organic and Inorganic Chemistry, Research Institute in Chemistry "Andrés M. del Río" (IQAR), Madrid, Spain; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine…
- Warsaw University of Technology, Institute of Micromechanics and Photonics, St A. Boboli 8 St., 02-525 Warsaw, Poland; Central Office of Measures, Elektoralna 2, 00-139 Warsaw, Poland.
Zitieren
APA
Węgierek-Ciuk, A., Baczewska, M., Gałczyńska, K., Ortega, P., de la Mata, F. J., Kujawińska, M., & Arabski, M. (2025). Enhanced methodology for analysis cytotoxicity of ruthenium dendrimers. Methods. https://doi.org/10.1016/j.ymeth.2025.02.009
Vancouver
Węgierek-Ciuk A, Baczewska M, Gałczyńska K, Ortega P, de la Mata FJ, Kujawińska M, et al. Enhanced methodology for analysis cytotoxicity of ruthenium dendrimers. Methods. 2025. doi:10.1016/j.ymeth.2025.02.009
BibTeX
@article{WgierekCiuk2025,
author = {Węgierek-Ciuk, Aneta and Baczewska, Maria and Gałczyńska, Katarzyna and Ortega, Paula and de la Mata, Francisco Javier and Kujawińska, Małgorzata and Arabski, Michał},
title = {Enhanced methodology for analysis cytotoxicity of ruthenium dendrimers},
journal = {Methods},
year = {2025},
doi = {10.1016/j.ymeth.2025.02.009}
}
EUVIMED